Product 6
Natural health product licensed in Canada
- Licence holder
- Company 123
- NPN or DIN-HM
- 80085138
- Status
- Active licence
- Licence date
- 11 May 2018
- Revision date
- 29 October 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Extrait de fève de café vert Source : Coffea arabica graine Potency : 45 % Chlorogenic acids | Not specified | Not calculated |
| Stérols végétaux libres Source : Brassica napus - entier Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
| Stérols végétaux libres Source : Secale cereale (Whole) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
| Stérols végétaux libres Source : Gossypium herbaceum (Seed) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
| Stérols végétaux libres Source : Olea europaea (Whole) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
| Stérols végétaux libres Source : Arachis hypogaea (Whole) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
| Stérols végétaux libres Source : Glycine max - Graine Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
| Stérols végétaux libres Source : Zea mays (Whole) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 50 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hydroxypropylcellulose, Silice, Gélatine, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Provides antioxidants. Could be a complement to a healthy lifestyle that incorporates a calorie-reduced diet and regular physical activity for individuals involved in a weight management program. Helps maintain healthy blood pressure levels. Helps support cardiovascular health. Glucomannan promotes bowel movements by increasing bulk volume and water content. Glucomannan provides gentle relief of constipation and/or irregularity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are pregnant or have difficulty swallowing.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding, or have diabetes. Consult a health care practitioner if symptoms worsen or if laxative effect does not occur within 7 days. Consult a health care practitioner prior to use if you have symptoms such as abdominal pain, nausea, vomiting or fever (as these could be signs of abnormal constrictions of the gastrointestinal tract, diseases of the oesophagus and/or the superior opening of the stomach (cardia), potential or existing intestinal blockage, paralysis of the intestine, megacolon, faecal impaction, inflamed bowel or appendicitis).
- Effets indésirables connus
If you experience chest pain, vomiting, or difficulty swallowing or breathing after taking the product, seek immediate medical attention. Loose stools, flatulence, diarrhea, and abdominal discomfort have been reported.
Source
Official Health Canada record, licence 80085138
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging